Protagonist Therapeutics Cash from Investing (TTM) Analysis

Protagonist Therapeutics Inc (PTGX)

26.32 -0.50 (-1.86%) USD | NASDAQ | Apr 24, 11:12

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-39.26M
September 30, 2023	25.96M
June 30, 2023	96.80M
March 31, 2023	105.77M
December 31, 2022	91.47M
September 30, 2022	115.40M
June 30, 2022	13.42M
March 31, 2022	-13.54M
December 31, 2021	-15.86M
September 30, 2021	-118.13M
June 30, 2021	-127.54M
March 31, 2021	-140.49M
December 31, 2020	-90.96M
September 30, 2020	-29.12M
June 30, 2020	-7.034M
March 31, 2020	-15.09M
December 31, 2019	-53.71M

Date	Value
September 30, 2019	-36.61M
June 30, 2019	5.349M
March 31, 2019	28.16M
December 31, 2018	2.213M
September 30, 2018	2.416M
June 30, 2018	-8.273M
March 31, 2018	-4.771M
December 31, 2017	15.82M
September 30, 2017	-53.25M
June 30, 2017	-48.60M
March 31, 2017	-67.72M
December 31, 2016	-59.33M
September 30, 2016	-3.088M
June 30, 2016	-7.085M
March 31, 2016	-1.112M
December 31, 2015	-8.264M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-140.49M

Minimum

Mar 2021

115.40M

Maximum

Sep 2022

-12.27M

Average

-15.09M

Median

Mar 2020

Cash from Investing (TTM) Benchmarks